Abstract
Gold-based metallodrugs have been used for a wide variety of medical–related applications. Although none of them have reached clinical trials, many compounds show potential for a plethora of possible applications. Platinum compounds, on the other hand, are the leading class of metallodrugs used for the treatment of cancer, with successful representatives worldwide, such as cisplatin, carboplatin and oxaliplatin. In this minireview, we will briefly present the development of metallodrugs based on such metals throughout the year of 2017.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Advances in Medical Biotechnology - IJAMB
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
